Inventor · disambiguated record
Tina Schwabe
Also filed as: SCHWABE TINA
22 granted patents·17 pending applications·68 citations·filing 2015–2025
94Inventor score
Top patents by PatentIndex Score
39 records- 0196US11186645B2Isolated nucleic acids encoding anti-sortilin antibodiesALECTOR LLC·Filed 2020·Granted Nov 30, 2021·4 cites·48 claims
- 0296US10676525B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 9, 2020·13 cites·60 claims
- 0394US10087255B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 2, 2018·12 cites·17 claims
- 0493US11208488B2Methods of increasing progranulin levels using anti-Sortilin antibodiesALECTOR LLC·Filed 2018·Granted Dec 28, 2021·4 cites·44 claims
- 0593US10849992B1Methods of screening for sortilin binding antagonistsALECTOR LLC·Filed 2016·Granted Dec 1, 2020·6 cites·8 claims
- 0691US11084875B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Aug 10, 2021·4 cites·26 claims
- 0791US10428150B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Oct 1, 2019·6 cites·17 claims
- 0891US2025092144A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2024·Application pending·0 cites
- 0990US11634489B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Apr 25, 2023·2 cites·32 claims
- 1090US10308718B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 4, 2019·6 cites·21 claims
- 1189US11667699B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jun 6, 2023·3 cites·93 claims
- 1289US11339223B2Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2018·Granted May 24, 2022·2 cites·59 claims
- 1388US11396546B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Jul 26, 2022·2 cites·22 claims
- 1486US11472874B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Oct 18, 2022·3 cites·29 claims
- 1582US2025297016A1Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 1681US11440957B2Anti-TMEM106B antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Sep 13, 2022·1 cites·43 claims
- 1780US2024309097A2Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryROSENTHAL ARNON·Filed 2022·Application pending·0 cites
- 1879US2022185899A1Methods of increasing progranulin levels using anti-sortilin antibodiesALECTOR LLC·Filed 2021·Application pending·0 cites
- 1979US2022185898A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2021·Application pending·0 cites
- 2077US12358991B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jul 15, 2025·0 cites·52 claims
- 2177US12297277B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 13, 2025·0 cites·53 claims
- 2275US2023312712A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 2375US2023107639A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 2474US12331111B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·24 claims
- 2574US12331112B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·28 claims
- 2671US2023295297A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 2769US12319734B2Anti-TMEM106B antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 3, 2025·0 cites·27 claims
- 2869US12215149B2Anti-MS4A6A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Feb 4, 2025·0 cites·19 claims
- 2968US12186409B2Methods of screening for sortilin binding antagonistsALECTOR LLC·Filed 2020·Granted Jan 7, 2025·0 cites·16 claims
- 3066US2024076362A1Anti-ms4a4a antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 3161US11470827B2Transgenic mice expressing human TREM proteins and methods of use thereofALECTOR LLC·Filed 2018·Granted Oct 18, 2022·0 cites·10 claims
- 3259US2019010230A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Application pending·0 cites
- 3359US2024174746A1Anti-tmem106b antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 3456US2021122817A1Anti-ms4a6a antibodies and methods of use thereofALECTOR LLC·Filed 2019·Application pending·0 cites
- 3551US2023159637A1Methods of use of anti-trem2 antibodiesALECTOR LLC·Filed 2021·Application pending·0 cites
- 3651US2017240631A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2015·Application pending·0 cites
- 3750US2024294650A1Anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2021·Application pending·0 cites
- 3848US2023024528A1Methods of use of anti-trem2 antibodiesALECTOR LLC·Filed 2020·Application pending·0 cites
- 3944US2019330335A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →